With operations in 60 countries and sales in over 180, Reckitt Benckiser expanded its retail team use of LumiData's SOLYS demand intelligence solution.
Reckitt Benckiser Group plc successfully completed its acquisition of Adams Respiratory Therapeutics Inc. through a cash tender offer followed by a short- form merger of its indirect wholly owned subsidiary, Twickenham Inc., with and into Adams.
Reckitt Benckiser Group plc and Adams Respiratory Therapeutics have entered into a definitive agreement under which Reckitt Benckiser will tender for the acquisition of Adams for $60 per share in cash ($2.3 billion).
At a recent shareholders meeting, P&G President and Chief Executive A. G. Lafley said, "We are now focused on delivering a full decade of industry-leading top and bottom line growth.